Bioneutral Group Inc (BONU) Financial Statements (2024 and earlier)

Company Profile

Business Address 211 WARREN STREET
NEWARK, NJ 07103
State of Incorp. NV
Fiscal Year End October 31
Industry (SIC) 281 - Industrial Inorganic Chemicals (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

7/31/2014
MRQ
10/31/2013
10/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 11
Cash and cash equivalents 11
Receivables 101
Inventory, net of allowances, customer advances and progress billings 143
Inventory 143
Total current assets: 255
Noncurrent Assets
Property, plant and equipment 01
Intangible assets, net (including goodwill) 9,2499,958
Intangible assets, net (excluding goodwill) 9,2499,958
Other noncurrent assets 3
Prepaid expense and other noncurrent assets14
Total noncurrent assets: 9,2529,973
TOTAL ASSETS: 9,2779,978
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 1,088975
Other undisclosed accounts payable and accrued liabilities 1,088975
Debt 268 
Deferred compensation liability 979168
Derivative instruments and hedges, liabilities 129 
Due to related parties 5870
Other undisclosed current liabilities 75417
Total current liabilities: 2,5961,630
Noncurrent Liabilities
Other undisclosed noncurrent liabilities 1,462788
Total noncurrent liabilities: 1,462788
Total liabilities: 4,0592,418
Temporary equity, carrying amount 00
Equity
Equity, attributable to parent, including: 5,3797,451
Common stock 31
Additional paid in capital 63,40363,991
Accumulated deficit (57,889)(54,968)
Other undisclosed equity, attributable to parent (137)(1,574)
Equity, attributable to noncontrolling interest (161)109
Total equity: 5,2197,560
Other undisclosed liabilities and equity (0)(0)
TOTAL LIABILITIES AND EQUITY: 9,2779,978

Income Statement (P&L) ($ in thousands)

7/31/2014
TTM
10/31/2013
10/31/2012
Revenues 215
Cost of revenue (15)(2)
Gross profit: 72
Operating expenses (3,073)(2,542)
Operating loss: (3,066)(2,540)
Nonoperating expense (125) 
Investment income, nonoperating 379 
Interest and debt expense (216)(66)
Other undisclosed income from continuing operations before equity method investments, income taxes 2160
Loss from continuing operations before income taxes: (3,191)(2,606)
Income tax expense  (2,305)
Loss from continuing operations: (3,191)(4,911)
Loss before gain (loss) on sale of properties: (3,191)(4,911)
Other undisclosed net income  2,305
Net loss: (3,191)(2,606)
Net income attributable to noncontrolling interest 269220
Net loss available to common stockholders, diluted: (2,921)(2,386)

Comprehensive Income ($ in thousands)

7/31/2014
TTM
10/31/2013
10/31/2012
Net loss: (3,191)(2,606)
Comprehensive loss: (3,191)(2,606)
Comprehensive loss, net of tax, attributable to noncontrolling interest (269)(220)
Comprehensive loss, net of tax, attributable to parent: (3,460)(2,826)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: